nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Lomustine—hematologic cancer	0.0634	0.189	CbGbCtD
Hydroxychloroquine—CYP2D6—Idarubicin—hematologic cancer	0.0565	0.168	CbGbCtD
Hydroxychloroquine—CYP2D6—Hydroxyurea—hematologic cancer	0.0481	0.143	CbGbCtD
Hydroxychloroquine—CYP2D6—Bortezomib—hematologic cancer	0.0418	0.124	CbGbCtD
Hydroxychloroquine—CYP2D6—Imatinib—hematologic cancer	0.0306	0.0912	CbGbCtD
Hydroxychloroquine—CYP2D6—Nilotinib—hematologic cancer	0.0278	0.0829	CbGbCtD
Hydroxychloroquine—CYP2D6—Vinorelbine—hematologic cancer	0.0276	0.0822	CbGbCtD
Hydroxychloroquine—CYP2D6—Vinblastine—hematologic cancer	0.017	0.0506	CbGbCtD
Hydroxychloroquine—TLR7—hematopoietic system—hematologic cancer	0.0127	0.236	CbGeAlD
Hydroxychloroquine—CYP2D6—Dexamethasone—hematologic cancer	0.0126	0.0375	CbGbCtD
Hydroxychloroquine—CYP2D6—Doxorubicin—hematologic cancer	0.0105	0.0311	CbGbCtD
Hydroxychloroquine—TLR7—gonad—hematologic cancer	0.00969	0.18	CbGeAlD
Hydroxychloroquine—TLR7—blood—hematologic cancer	0.00844	0.157	CbGeAlD
Hydroxychloroquine—TLR7—lung—hematologic cancer	0.0074	0.137	CbGeAlD
Hydroxychloroquine—TLR7—testis—hematologic cancer	0.00698	0.129	CbGeAlD
Hydroxychloroquine—TLR7—lymph node—hematologic cancer	0.00506	0.0939	CbGeAlD
Hydroxychloroquine—CYP2D6—hematopoietic system—hematologic cancer	0.00163	0.0303	CbGeAlD
Hydroxychloroquine—CYP2D6—blood—hematologic cancer	0.00108	0.0201	CbGeAlD
Hydroxychloroquine—CYP2D6—testis—hematologic cancer	0.000896	0.0166	CbGeAlD
Hydroxychloroquine—Chloroquine—TNF—hematologic cancer	0.000816	0.538	CrCbGaD
Hydroxychloroquine—Quinacrine—ABCB1—hematologic cancer	0.000372	0.245	CrCbGaD
Hydroxychloroquine—Chloroquine—ABCB1—hematologic cancer	0.00033	0.217	CrCbGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTGER4—hematologic cancer	6.91e-05	0.000339	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LCK—hematologic cancer	6.88e-05	0.000338	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDGFRA—hematologic cancer	6.85e-05	0.000337	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JAK1—hematologic cancer	6.83e-05	0.000335	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PRKCG—hematologic cancer	6.83e-05	0.000335	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—hematologic cancer	6.82e-05	0.000335	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-B—hematologic cancer	6.81e-05	0.000334	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—H3F3A—hematologic cancer	6.74e-05	0.000331	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD80—hematologic cancer	6.74e-05	0.000331	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KIT—hematologic cancer	6.72e-05	0.00033	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTPN11—hematologic cancer	6.61e-05	0.000324	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1B—hematologic cancer	6.56e-05	0.000322	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRKCZ—hematologic cancer	6.55e-05	0.000322	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK3—hematologic cancer	6.53e-05	0.000321	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FOS—hematologic cancer	6.41e-05	0.000315	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CREB1—hematologic cancer	6.4e-05	0.000314	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2RA—hematologic cancer	6.38e-05	0.000313	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PARP1—hematologic cancer	6.33e-05	0.000311	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-A—hematologic cancer	6.31e-05	0.00031	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CASP8—hematologic cancer	6.26e-05	0.000307	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—JUN—hematologic cancer	6.25e-05	0.000307	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6R—hematologic cancer	6.24e-05	0.000307	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CREBBP—hematologic cancer	6.23e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FBXW7—hematologic cancer	6.23e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Prednisone—hematologic cancer	6.21e-05	0.000153	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Gemcitabine—hematologic cancer	6.2e-05	0.000153	CcSEcCtD
Hydroxychloroquine—Nausea—Thalidomide—hematologic cancer	6.19e-05	0.000153	CcSEcCtD
Hydroxychloroquine—Rash—Ifosfamide—hematologic cancer	6.18e-05	0.000153	CcSEcCtD
Hydroxychloroquine—Dermatitis—Ifosfamide—hematologic cancer	6.18e-05	0.000153	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—hematologic cancer	6.17e-05	0.000152	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PDGFB—hematologic cancer	6.16e-05	0.000302	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Irinotecan—hematologic cancer	6.16e-05	0.000152	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—hematologic cancer	6.15e-05	0.000152	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—hematologic cancer	6.14e-05	0.000152	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—hematologic cancer	6.12e-05	0.000151	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—hematologic cancer	6.12e-05	0.000151	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—hematologic cancer	6.11e-05	0.000151	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—hematologic cancer	6.11e-05	0.000151	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCR4—hematologic cancer	6.11e-05	0.0003	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HDAC2—hematologic cancer	6.11e-05	0.0003	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Methotrexate—hematologic cancer	6.1e-05	0.000151	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—hematologic cancer	6.09e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—hematologic cancer	6.08e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Anorexia—Dexamethasone—hematologic cancer	6.07e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Anorexia—Betamethasone—hematologic cancer	6.07e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisolone—hematologic cancer	6.07e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Asthenia—Cisplatin—hematologic cancer	6.06e-05	0.00015	CcSEcCtD
Hydroxychloroquine—Fatigue—Triamcinolone—hematologic cancer	6.06e-05	0.00015	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1A—hematologic cancer	6.06e-05	0.000297	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2L1—hematologic cancer	6.06e-05	0.000297	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—hematologic cancer	6.04e-05	0.000297	CbGpPWpGaD
Hydroxychloroquine—Rash—Vincristine—hematologic cancer	6.03e-05	0.000149	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—hematologic cancer	6.02e-05	0.000149	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TSC2—hematologic cancer	6.02e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CRP—hematologic cancer	6.02e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—Pain—Triamcinolone—hematologic cancer	6.01e-05	0.000148	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—hematologic cancer	5.99e-05	0.000148	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisone—hematologic cancer	5.98e-05	0.000148	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CBL—hematologic cancer	5.95e-05	0.000292	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAP2K1—hematologic cancer	5.95e-05	0.000292	CbGpPWpGaD
Hydroxychloroquine—Nausea—Carmustine—hematologic cancer	5.95e-05	0.000147	CcSEcCtD
Hydroxychloroquine—Vomiting—Irinotecan—hematologic cancer	5.92e-05	0.000146	CcSEcCtD
Hydroxychloroquine—Vomiting—Mitoxantrone—hematologic cancer	5.92e-05	0.000146	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—hematologic cancer	5.91e-05	0.00029	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK8—hematologic cancer	5.91e-05	0.00029	CbGpPWpGaD
Hydroxychloroquine—Nausea—Alitretinoin—hematologic cancer	5.89e-05	0.000146	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—hematologic cancer	5.89e-05	0.000146	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—IL3—hematologic cancer	5.89e-05	0.000289	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Epirubicin—hematologic cancer	5.89e-05	0.000145	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—hematologic cancer	5.88e-05	0.000145	CcSEcCtD
Hydroxychloroquine—Rash—Irinotecan—hematologic cancer	5.87e-05	0.000145	CcSEcCtD
Hydroxychloroquine—Rash—Mitoxantrone—hematologic cancer	5.87e-05	0.000145	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—hematologic cancer	5.87e-05	0.000288	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Mitoxantrone—hematologic cancer	5.86e-05	0.000145	CcSEcCtD
Hydroxychloroquine—Dermatitis—Irinotecan—hematologic cancer	5.86e-05	0.000145	CcSEcCtD
Hydroxychloroquine—Headache—Mitoxantrone—hematologic cancer	5.83e-05	0.000144	CcSEcCtD
Hydroxychloroquine—Headache—Irinotecan—hematologic cancer	5.83e-05	0.000144	CcSEcCtD
Hydroxychloroquine—Nausea—Ifosfamide—hematologic cancer	5.82e-05	0.000144	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FGFR3—hematologic cancer	5.79e-05	0.000284	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTPN1—hematologic cancer	5.79e-05	0.000284	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Cisplatin—hematologic cancer	5.78e-05	0.000143	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—hematologic cancer	5.78e-05	0.000143	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—hematologic cancer	5.77e-05	0.000142	CcSEcCtD
Hydroxychloroquine—Vomiting—Gemcitabine—hematologic cancer	5.77e-05	0.000142	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EP300—hematologic cancer	5.76e-05	0.000283	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.75e-05	0.000142	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MAPK14—hematologic cancer	5.73e-05	0.000281	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Methotrexate—hematologic cancer	5.72e-05	0.000141	CcSEcCtD
Hydroxychloroquine—Rash—Gemcitabine—hematologic cancer	5.72e-05	0.000141	CcSEcCtD
Hydroxychloroquine—Dermatitis—Gemcitabine—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—hematologic cancer	5.7e-05	0.000141	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RASGRP1—hematologic cancer	5.69e-05	0.00028	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Methotrexate—hematologic cancer	5.68e-05	0.00014	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—hematologic cancer	5.68e-05	0.00014	CcSEcCtD
Hydroxychloroquine—Headache—Gemcitabine—hematologic cancer	5.68e-05	0.00014	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—hematologic cancer	5.68e-05	0.00014	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HSP90AA1—hematologic cancer	5.68e-05	0.000279	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SYK—hematologic cancer	5.68e-05	0.000279	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FGF2—hematologic cancer	5.66e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Doxorubicin—hematologic cancer	5.65e-05	0.00014	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisolone—hematologic cancer	5.63e-05	0.000139	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—hematologic cancer	5.6e-05	0.000275	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3R1—hematologic cancer	5.58e-05	0.000274	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Triamcinolone—hematologic cancer	5.58e-05	0.000138	CcSEcCtD
Hydroxychloroquine—Asthenia—Etoposide—hematologic cancer	5.56e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Triamcinolone—hematologic cancer	5.55e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—hematologic cancer	5.55e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Betamethasone—hematologic cancer	5.54e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dexamethasone—hematologic cancer	5.54e-05	0.000137	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ICAM1—hematologic cancer	5.53e-05	0.000272	CbGpPWpGaD
Hydroxychloroquine—Nausea—Irinotecan—hematologic cancer	5.53e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Nausea—Mitoxantrone—hematologic cancer	5.53e-05	0.000137	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.5e-05	0.000136	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.5e-05	0.000136	CcSEcCtD
Hydroxychloroquine—Fatigue—Betamethasone—hematologic cancer	5.49e-05	0.000136	CcSEcCtD
Hydroxychloroquine—Fatigue—Dexamethasone—hematologic cancer	5.49e-05	0.000136	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NFKBIA—hematologic cancer	5.49e-05	0.000269	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BAD—hematologic cancer	5.49e-05	0.000269	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Etoposide—hematologic cancer	5.48e-05	0.000135	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT1—hematologic cancer	5.47e-05	0.000269	CbGpPWpGaD
Hydroxychloroquine—Pain—Dexamethasone—hematologic cancer	5.45e-05	0.000135	CcSEcCtD
Hydroxychloroquine—Pain—Betamethasone—hematologic cancer	5.45e-05	0.000135	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—hematologic cancer	5.45e-05	0.000135	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—hematologic cancer	5.44e-05	0.000134	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—JAK2—hematologic cancer	5.42e-05	0.000266	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Epirubicin—hematologic cancer	5.4e-05	0.000133	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—hematologic cancer	5.39e-05	0.000265	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Prednisone—hematologic cancer	5.39e-05	0.000133	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—hematologic cancer	5.39e-05	0.000265	CbGpPWpGaD
Hydroxychloroquine—Nausea—Gemcitabine—hematologic cancer	5.39e-05	0.000133	CcSEcCtD
Hydroxychloroquine—Vomiting—Cisplatin—hematologic cancer	5.37e-05	0.000133	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—BCL2—hematologic cancer	5.37e-05	0.000264	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Methotrexate—hematologic cancer	5.36e-05	0.000132	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—hematologic cancer	5.35e-05	0.000132	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—hematologic cancer	5.35e-05	0.000132	CcSEcCtD
Hydroxychloroquine—Rash—Cisplatin—hematologic cancer	5.33e-05	0.000132	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cisplatin—hematologic cancer	5.32e-05	0.000131	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNG—hematologic cancer	5.32e-05	0.000261	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD80—hematologic cancer	5.32e-05	0.000261	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Epirubicin—hematologic cancer	5.32e-05	0.000131	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—KIT—hematologic cancer	5.31e-05	0.000261	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Etoposide—hematologic cancer	5.3e-05	0.000131	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	5.3e-05	0.00026	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MDM2—hematologic cancer	5.3e-05	0.00026	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Prednisone—hematologic cancer	5.29e-05	0.000131	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—hematologic cancer	5.28e-05	0.00013	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—hematologic cancer	5.27e-05	0.00013	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—hematologic cancer	5.25e-05	0.00013	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	5.22e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTPN11—hematologic cancer	5.22e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—Tension—Epirubicin—hematologic cancer	5.22e-05	0.000129	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.21e-05	0.000129	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Betamethasone—hematologic cancer	5.21e-05	0.000129	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Triamcinolone—hematologic cancer	5.17e-05	0.000128	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—hematologic cancer	5.17e-05	0.000128	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK3—hematologic cancer	5.16e-05	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MTOR—hematologic cancer	5.15e-05	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—hematologic cancer	5.15e-05	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—hematologic cancer	5.14e-05	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GRB2—hematologic cancer	5.12e-05	0.000251	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Etoposide—hematologic cancer	5.12e-05	0.000126	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFA—hematologic cancer	5.11e-05	0.000251	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Methotrexate—hematologic cancer	5.11e-05	0.000126	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—hematologic cancer	5.09e-05	0.000126	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FOS—hematologic cancer	5.07e-05	0.000249	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Betamethasone—hematologic cancer	5.06e-05	0.000125	CcSEcCtD
Hydroxychloroquine—Urticaria—Dexamethasone—hematologic cancer	5.06e-05	0.000125	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CREB1—hematologic cancer	5.06e-05	0.000248	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Prednisolone—hematologic cancer	5.05e-05	0.000125	CcSEcCtD
Hydroxychloroquine—Asthenia—Triamcinolone—hematologic cancer	5.04e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Betamethasone—hematologic cancer	5.04e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Betamethasone—hematologic cancer	5.04e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dexamethasone—hematologic cancer	5.04e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dexamethasone—hematologic cancer	5.04e-05	0.000124	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—KITLG—hematologic cancer	5.04e-05	0.000247	CbGpPWpGaD
Hydroxychloroquine—Nausea—Cisplatin—hematologic cancer	5.02e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—hematologic cancer	5.01e-05	0.000124	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—hematologic cancer	5e-05	0.000123	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—hematologic cancer	4.99e-05	0.000245	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Triamcinolone—hematologic cancer	4.97e-05	0.000123	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—hematologic cancer	4.95e-05	0.000122	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CASP8—hematologic cancer	4.95e-05	0.000243	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6R—hematologic cancer	4.93e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CREBBP—hematologic cancer	4.93e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Methotrexate—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Hydroxychloroquine—Vomiting—Etoposide—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT5A—hematologic cancer	4.92e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Doxorubicin—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—hematologic cancer	4.92e-05	0.000121	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—hematologic cancer	4.89e-05	0.000121	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—hematologic cancer	4.88e-05	0.000121	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN2B—hematologic cancer	4.88e-05	0.00024	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Etoposide—hematologic cancer	4.88e-05	0.00012	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	4.87e-05	0.000239	CbGpPWpGaD
Hydroxychloroquine—Headache—Etoposide—hematologic cancer	4.85e-05	0.00012	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—hematologic cancer	4.83e-05	0.000237	CbGpPWpGaD
Hydroxychloroquine—Tension—Doxorubicin—hematologic cancer	4.83e-05	0.000119	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Prednisone—hematologic cancer	4.82e-05	0.000119	CcSEcCtD
Hydroxychloroquine—Rash—Prednisolone—hematologic cancer	4.82e-05	0.000119	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisolone—hematologic cancer	4.81e-05	0.000119	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.81e-05	0.000119	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	4.8e-05	0.000236	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Prednisone—hematologic cancer	4.79e-05	0.000118	CcSEcCtD
Hydroxychloroquine—Headache—Prednisolone—hematologic cancer	4.78e-05	0.000118	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—hematologic cancer	4.78e-05	0.000118	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—hematologic cancer	4.78e-05	0.000118	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—hematologic cancer	4.77e-05	0.000234	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Epirubicin—hematologic cancer	4.76e-05	0.000118	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IL1B—hematologic cancer	4.75e-05	0.000233	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—hematologic cancer	4.73e-05	0.000232	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CD86—hematologic cancer	4.72e-05	0.000232	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAP2K1—hematologic cancer	4.7e-05	0.000231	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Epirubicin—hematologic cancer	4.67e-05	0.000115	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—hematologic cancer	4.67e-05	0.000229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HES1—hematologic cancer	4.65e-05	0.000229	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Triamcinolone—hematologic cancer	4.64e-05	0.000115	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—hematologic cancer	4.64e-05	0.000228	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Doxorubicin—hematologic cancer	4.64e-05	0.000115	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NCOR1—hematologic cancer	4.63e-05	0.000227	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Epirubicin—hematologic cancer	4.61e-05	0.000114	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—JUN—hematologic cancer	4.6e-05	0.000226	CbGpPWpGaD
Hydroxychloroquine—Nausea—Etoposide—hematologic cancer	4.6e-05	0.000114	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF1—hematologic cancer	4.58e-05	0.000225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CSF2—hematologic cancer	4.58e-05	0.000225	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Dexamethasone—hematologic cancer	4.57e-05	0.000113	CcSEcCtD
Hydroxychloroquine—Asthenia—Betamethasone—hematologic cancer	4.57e-05	0.000113	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—hematologic cancer	4.55e-05	0.000112	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—hematologic cancer	4.55e-05	0.000112	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—hematologic cancer	4.54e-05	0.000112	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—hematologic cancer	4.54e-05	0.000112	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisolone—hematologic cancer	4.54e-05	0.000112	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—hematologic cancer	4.52e-05	0.000112	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FOXO1—hematologic cancer	4.51e-05	0.000221	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Dexamethasone—hematologic cancer	4.51e-05	0.000111	CcSEcCtD
Hydroxychloroquine—Pruritus—Betamethasone—hematologic cancer	4.51e-05	0.000111	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—hematologic cancer	4.51e-05	0.000111	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRB—hematologic cancer	4.5e-05	0.000221	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.5e-05	0.000111	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FGF2—hematologic cancer	4.47e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Triamcinolone—hematologic cancer	4.47e-05	0.00011	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—hematologic cancer	4.46e-05	0.000219	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTEN—hematologic cancer	4.45e-05	0.000219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRA—hematologic cancer	4.43e-05	0.000218	CbGpPWpGaD
Hydroxychloroquine—Rash—Triamcinolone—hematologic cancer	4.43e-05	0.000109	CcSEcCtD
Hydroxychloroquine—Dermatitis—Triamcinolone—hematologic cancer	4.42e-05	0.000109	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—hematologic cancer	4.42e-05	0.000109	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—hematologic cancer	4.42e-05	0.000109	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—JAK1—hematologic cancer	4.42e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRKCG—hematologic cancer	4.42e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3R1—hematologic cancer	4.41e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Prednisone—hematologic cancer	4.41e-05	0.000109	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—hematologic cancer	4.41e-05	0.000109	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—hematologic cancer	4.4e-05	0.000216	CbGpPWpGaD
Hydroxychloroquine—Headache—Triamcinolone—hematologic cancer	4.4e-05	0.000109	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—hematologic cancer	4.39e-05	0.000108	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—hematologic cancer	4.39e-05	0.000108	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Betamethasone—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dexamethasone—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—MAPK8—hematologic cancer	4.35e-05	0.000214	CbGpPWpGaD
Hydroxychloroquine—Oedema—Epirubicin—hematologic cancer	4.34e-05	0.000107	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—hematologic cancer	4.33e-05	0.000107	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—JAK2—hematologic cancer	4.29e-05	0.000211	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Doxorubicin—hematologic cancer	4.26e-05	0.000105	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—hematologic cancer	4.26e-05	0.000209	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Epirubicin—hematologic cancer	4.26e-05	0.000105	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—hematologic cancer	4.25e-05	0.000105	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—BCL2—hematologic cancer	4.25e-05	0.000209	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EP300—hematologic cancer	4.25e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Epirubicin—hematologic cancer	4.22e-05	0.000104	CcSEcCtD
Hydroxychloroquine—Dizziness—Dexamethasone—hematologic cancer	4.21e-05	0.000104	CcSEcCtD
Hydroxychloroquine—Dizziness—Betamethasone—hematologic cancer	4.21e-05	0.000104	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNG—hematologic cancer	4.21e-05	0.000207	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MDM2—hematologic cancer	4.19e-05	0.000206	CbGpPWpGaD
Hydroxychloroquine—Nausea—Triamcinolone—hematologic cancer	4.17e-05	0.000103	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.16e-05	0.000103	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—hematologic cancer	4.14e-05	0.000102	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—SRC—hematologic cancer	4.13e-05	0.000203	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2RA—hematologic cancer	4.12e-05	0.000203	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Methotrexate—hematologic cancer	4.12e-05	0.000102	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisone—hematologic cancer	4.09e-05	0.000101	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—hematologic cancer	4.08e-05	0.0002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MTOR—hematologic cancer	4.07e-05	0.0002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—hematologic cancer	4.07e-05	0.0002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—hematologic cancer	4.06e-05	0.0002	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PHYH—hematologic cancer	4.06e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FTCD—hematologic cancer	4.06e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GMPS—hematologic cancer	4.06e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Betamethasone—hematologic cancer	4.05e-05	0.0001	CcSEcCtD
Hydroxychloroquine—Vomiting—Dexamethasone—hematologic cancer	4.05e-05	0.0001	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—hematologic cancer	4.03e-05	9.96e-05	CcSEcCtD
Hydroxychloroquine—Rash—Dexamethasone—hematologic cancer	4.02e-05	9.92e-05	CcSEcCtD
Hydroxychloroquine—Rash—Betamethasone—hematologic cancer	4.02e-05	9.92e-05	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—hematologic cancer	4.02e-05	9.92e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Betamethasone—hematologic cancer	4.01e-05	9.91e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Dexamethasone—hematologic cancer	4.01e-05	9.91e-05	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—hematologic cancer	4e-05	9.89e-05	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—hematologic cancer	4e-05	9.88e-05	CcSEcCtD
Hydroxychloroquine—Headache—Dexamethasone—hematologic cancer	3.99e-05	9.86e-05	CcSEcCtD
Hydroxychloroquine—Headache—Betamethasone—hematologic cancer	3.99e-05	9.86e-05	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—hematologic cancer	3.98e-05	9.83e-05	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—STAT3—hematologic cancer	3.98e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFB—hematologic cancer	3.98e-05	0.000195	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—hematologic cancer	3.97e-05	0.000195	CbGpPWpGaD
Hydroxychloroquine—Pain—Methotrexate—hematologic cancer	3.97e-05	9.79e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—hematologic cancer	3.94e-05	0.000194	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—hematologic cancer	3.94e-05	9.73e-05	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.93e-05	9.71e-05	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—hematologic cancer	3.93e-05	9.7e-05	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—hematologic cancer	3.9e-05	9.63e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TSC2—hematologic cancer	3.89e-05	0.000191	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Epirubicin—hematologic cancer	3.86e-05	9.53e-05	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—hematologic cancer	3.83e-05	9.45e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—hematologic cancer	3.82e-05	0.000188	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK3—hematologic cancer	3.8e-05	0.000187	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—hematologic cancer	3.8e-05	9.38e-05	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.79e-05	9.37e-05	CcSEcCtD
Hydroxychloroquine—Nausea—Dexamethasone—hematologic cancer	3.79e-05	9.35e-05	CcSEcCtD
Hydroxychloroquine—Nausea—Betamethasone—hematologic cancer	3.79e-05	9.35e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—hematologic cancer	3.77e-05	0.000185	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—hematologic cancer	3.77e-05	9.32e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IL1B—hematologic cancer	3.75e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.75e-05	9.25e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR3—hematologic cancer	3.74e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Epirubicin—hematologic cancer	3.74e-05	9.24e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IL2—hematologic cancer	3.74e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SMPD3—hematologic cancer	3.71e-05	0.000182	CbGpPWpGaD
Hydroxychloroquine—Pain—Epirubicin—hematologic cancer	3.71e-05	9.17e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK14—hematologic cancer	3.71e-05	0.000182	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Methotrexate—hematologic cancer	3.68e-05	9.1e-05	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—hematologic cancer	3.67e-05	9.06e-05	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—hematologic cancer	3.67e-05	9.05e-05	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—hematologic cancer	3.67e-05	9.05e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—JUN—hematologic cancer	3.64e-05	0.000179	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—hematologic cancer	3.64e-05	0.000179	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FN1—hematologic cancer	3.59e-05	0.000176	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—hematologic cancer	3.57e-05	8.82e-05	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.55e-05	8.77e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKBIA—hematologic cancer	3.55e-05	0.000174	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BAD—hematologic cancer	3.55e-05	0.000174	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Prednisone—hematologic cancer	3.53e-05	8.71e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—hematologic cancer	3.53e-05	0.000173	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—hematologic cancer	3.52e-05	0.000173	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH1—hematologic cancer	3.51e-05	0.000173	CbGpPWpGaD
Hydroxychloroquine—Rash—Prednisone—hematologic cancer	3.5e-05	8.64e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—hematologic cancer	3.5e-05	8.63e-05	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—hematologic cancer	3.49e-05	8.62e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—hematologic cancer	3.48e-05	0.000171	CbGpPWpGaD
Hydroxychloroquine—Headache—Prednisone—hematologic cancer	3.48e-05	8.59e-05	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.47e-05	8.56e-05	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—hematologic cancer	3.46e-05	8.55e-05	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—hematologic cancer	3.45e-05	8.52e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MAPK8—hematologic cancer	3.44e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CD80—hematologic cancer	3.44e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KIT—hematologic cancer	3.44e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—hematologic cancer	3.44e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—Pain—Doxorubicin—hematologic cancer	3.43e-05	8.48e-05	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—hematologic cancer	3.43e-05	8.47e-05	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—hematologic cancer	3.43e-05	8.47e-05	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KRAS—hematologic cancer	3.42e-05	0.000168	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Methotrexate—hematologic cancer	3.42e-05	8.44e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PTPN11—hematologic cancer	3.38e-05	0.000166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EP300—hematologic cancer	3.36e-05	0.000165	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Methotrexate—hematologic cancer	3.33e-05	8.22e-05	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisone—hematologic cancer	3.3e-05	8.14e-05	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.28e-05	8.11e-05	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—hematologic cancer	3.28e-05	8.1e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CREB1—hematologic cancer	3.27e-05	0.000161	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—hematologic cancer	3.26e-05	0.00016	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—DCK—hematologic cancer	3.25e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ASNS—hematologic cancer	3.25e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	3.25e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—hematologic cancer	3.23e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL2—hematologic cancer	3.2e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—hematologic cancer	3.2e-05	7.9e-05	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—hematologic cancer	3.19e-05	7.88e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6R—hematologic cancer	3.19e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CREBBP—hematologic cancer	3.19e-05	0.000156	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Doxorubicin—hematologic cancer	3.18e-05	7.84e-05	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—hematologic cancer	3.18e-05	7.84e-05	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—hematologic cancer	3.17e-05	7.84e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—STAT3—hematologic cancer	3.15e-05	0.000155	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—hematologic cancer	3.14e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—hematologic cancer	3.14e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—hematologic cancer	3.11e-05	7.69e-05	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—HDC—hematologic cancer	3.08e-05	0.000151	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—hematologic cancer	3.07e-05	7.58e-05	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—hematologic cancer	3.07e-05	7.57e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—MAP2K1—hematologic cancer	3.04e-05	0.000149	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—hematologic cancer	3.02e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK3—hematologic cancer	3.01e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—hematologic cancer	2.97e-05	7.33e-05	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—hematologic cancer	2.96e-05	7.31e-05	CcSEcCtD
Hydroxychloroquine—Vomiting—Methotrexate—hematologic cancer	2.95e-05	7.28e-05	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—hematologic cancer	2.92e-05	7.22e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—hematologic cancer	2.92e-05	7.22e-05	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—hematologic cancer	2.91e-05	7.18e-05	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HRAS—hematologic cancer	2.91e-05	0.000143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF2—hematologic cancer	2.89e-05	0.000142	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—hematologic cancer	2.88e-05	7.12e-05	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—hematologic cancer	2.87e-05	7.09e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3R1—hematologic cancer	2.85e-05	0.00014	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—hematologic cancer	2.84e-05	7.02e-05	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—CDA—hematologic cancer	2.81e-05	0.000138	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—hematologic cancer	2.78e-05	0.000137	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JAK2—hematologic cancer	2.77e-05	0.000136	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—hematologic cancer	2.76e-05	6.82e-05	CcSEcCtD
Hydroxychloroquine—Nausea—Methotrexate—hematologic cancer	2.76e-05	6.8e-05	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—hematologic cancer	2.75e-05	6.79e-05	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—hematologic cancer	2.74e-05	6.76e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—hematologic cancer	2.73e-05	6.75e-05	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—hematologic cancer	2.72e-05	6.72e-05	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—PC—hematologic cancer	2.71e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDM2—hematologic cancer	2.71e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—hematologic cancer	2.7e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—hematologic cancer	2.66e-05	6.56e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—hematologic cancer	2.63e-05	0.000129	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTOR—hematologic cancer	2.63e-05	0.000129	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.62e-05	0.000128	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GBA—hematologic cancer	2.62e-05	0.000128	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—hematologic cancer	2.58e-05	6.37e-05	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—AKT1—hematologic cancer	2.57e-05	0.000126	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—hematologic cancer	2.55e-05	6.31e-05	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—hematologic cancer	2.53e-05	6.25e-05	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—hematologic cancer	2.53e-05	6.25e-05	CcSEcCtD
Hydroxychloroquine—Headache—Doxorubicin—hematologic cancer	2.52e-05	6.21e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—hematologic cancer	2.48e-05	0.000122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—hematologic cancer	2.47e-05	0.000121	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—hematologic cancer	2.42e-05	0.000119	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—hematologic cancer	2.42e-05	0.000119	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTAP—hematologic cancer	2.39e-05	0.000117	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—hematologic cancer	2.39e-05	5.89e-05	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—hematologic cancer	2.36e-05	0.000116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—hematologic cancer	2.35e-05	0.000116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—hematologic cancer	2.3e-05	0.000113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—hematologic cancer	2.28e-05	0.000112	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—hematologic cancer	2.28e-05	0.000112	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK8—hematologic cancer	2.23e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—hematologic cancer	2.2e-05	0.000108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EP300—hematologic cancer	2.17e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FHL2—hematologic cancer	2.13e-05	0.000105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—hematologic cancer	2.11e-05	0.000104	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AGRN—hematologic cancer	2.09e-05	0.000103	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—hematologic cancer	2.06e-05	0.000101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—hematologic cancer	2.03e-05	9.99e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—hematologic cancer	2.03e-05	9.97e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—hematologic cancer	2.03e-05	9.96e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.98e-05	9.73e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.98e-05	9.73e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK3—hematologic cancer	1.94e-05	9.55e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—hematologic cancer	1.89e-05	9.28e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—hematologic cancer	1.89e-05	9.26e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.86e-05	9.15e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.81e-05	8.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA9—hematologic cancer	1.81e-05	8.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.79e-05	8.79e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—hematologic cancer	1.75e-05	8.58e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.7e-05	8.37e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.69e-05	8.28e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.69e-05	8.28e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TXN—hematologic cancer	1.69e-05	8.28e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.65e-05	8.1e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—hematologic cancer	1.61e-05	7.88e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.58e-05	7.78e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—hematologic cancer	1.55e-05	7.62e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.54e-05	7.57e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.54e-05	7.57e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.5e-05	7.38e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—hematologic cancer	1.48e-05	7.29e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.46e-05	7.14e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—hematologic cancer	1.42e-05	6.98e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.41e-05	6.94e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.41e-05	6.94e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NUP214—hematologic cancer	1.4e-05	6.89e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.37e-05	6.75e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTR—hematologic cancer	1.37e-05	6.75e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO2—hematologic cancer	1.35e-05	6.62e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—hematologic cancer	1.31e-05	6.44e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.31e-05	6.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SDC1—hematologic cancer	1.28e-05	6.27e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CD44—hematologic cancer	1.09e-05	5.33e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NQO1—hematologic cancer	1.09e-05	5.33e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYCS—hematologic cancer	1.03e-05	5.05e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.02e-05	5.01e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—hematologic cancer	9.06e-06	4.45e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—hematologic cancer	8.58e-06	4.21e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOR1—hematologic cancer	8.33e-06	4.09e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—hematologic cancer	8.33e-06	4.09e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—hematologic cancer	7.36e-06	3.61e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	6.18e-06	3.04e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.73e-06	2.81e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.43e-06	2.67e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—hematologic cancer	5.36e-06	2.63e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	5.13e-06	2.52e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.74e-06	2.33e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—hematologic cancer	4.09e-06	2.01e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EP300—hematologic cancer	3.9e-06	1.92e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.89e-06	1.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.36e-06	1.16e-05	CbGpPWpGaD
